FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-110221.
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.08-110221v1
23/1/204    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, W.
Right arrow Articles by Karhausen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, W.
Right arrow Articles by Karhausen, J.
(The FASEB Journal. 2009;23:204-213.)
© 2009 FASEB

Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium

Wen Zheng*,1, Johannes Kuhlicke{dagger},1, Kristian Jäckel{dagger}, Holger K. Eltzschig{dagger},{ddagger}, Anurag Singh*, Markus Sjöblom*,2, Brigitte Riederer*, Cornelia Weinhold*, Ursula Seidler*, Sean P. Colgan{ddagger} and Jörn Karhausen{dagger},3

* Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover, Germany;

{dagger} Universitätsklinik für Anästhesiologie und Intensivmedizin, Eberhard-Karls Universität Tübingen, Tübingen, Germany; and

{ddagger} Mucosal Inflammation Program, Division of Gastroenterology, University of Colorado, Health Sciences Center, Denver, Colorado, USA

3 Correspondence: Universitätsklinik für Anästhesiologie und Intensivmedizin, Eberhard-Karls Universität Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany. E-mail: joern.karhausen{at}medizin.uni-tuebingen.de

Diarrhea is widespread in intestinal diseases involving ischemia and/or hypoxia. Since hypoxia alters stimulated Cl and water flux, we investigated the influence of such a physiologically and pathophysiologically important signal on expression of the cystic fibrosis transmembrane conductance regulator (CFTR). Located on the apical membrane, this cAMP-activated Cl channel determines salt and fluid transport across mucosal surfaces. Our studies revealed depression of CFTR mRNA, protein, and function in hypoxic epithelia. Chromatin immunoprecipitation identified a previously unappreciated binding site for the hypoxia inducible factor-1 (HIF-1), and promoter studies established its relevance by loss of repression following point mutation. Consequently, HIF-1 overexpressing cells exhibited significantly reduced transport capacity in colorimetric Cl efflux studies, altered short circuit measurements, and changes in transepithelial fluid movement. Whole-body hypoxia in wild-type mice resulted in significantly reduced small intestinal fluid and HCO3 secretory responses to forskolin. Experiments performed in Cftr–/– and Nkcc1–/– mice underlined the role of altered CFTR expression for these functional changes, and work in conditional Hif1a mutant mice verified HIF-1-dependent CFTR regulation in vivo. In summary, our study clarifies CFTR regulation and introduces the concept of a HIF-1-orchestrated response designed to regulate ion and fluid movement across hypoxic intestinal epithelia.—Zheng, W., Kuhlicke, J., Jäckel, K., Eltzschig, H. K., Singh, A., Sjöblom, M., Riederer, B., Weinhold, C., Seidler, U., Colgan, S. P., Karhausen, J. Hypoxia inducible factor-1 (HIF-1) -mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium.


Key Words: anion transporter • ion movement • fluid secretion • mucosa







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.